naltrexone and nalbuphine

naltrexone has been researched along with nalbuphine in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (13.04)	18.7374
1990's	20 (43.48)	18.2507
2000's	16 (34.78)	29.6817
2010's	3 (6.52)	24.3611
2020's	1 (2.17)	2.80

Authors

Authors	Studies
Bell, GI; Breder, CD; Kong, H; Raynor, K; Reisine, T; Takeda, J; Yasuda, K	1
Strassburg, CP; Tukey, RH	1
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Bidlack, JM; Bu, Y; Cohen, DJ; Denhardt, C; Ganorkar, R; Guo, C; Jin, J; Lou, R; Lu, Q; VanAlstine, MA; Wentland, MP	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Archer, S; Michne, WF	1
Gehrmann, JE; Killam, KF	1
Pasternak, GW; Paul, D; Pick, CG	1
Lopez, J; Naujokat, P; Toledo-Pereyra, LH; Walters, W; Xavier, R	1
Dykstra, LA	1
Gurll, NJ; Holaday, JW; Lechner, RB; Reynolds, DG	1
Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM	1
Erking, W; Lücker, PW; Wetzelsberger, N	1
Hameroff, SR	1
Bagley, JR; Brockunier, LL; Flynn, D; France, CP; Gerak, LR; Medzihradsky, F; Winger, GD; Woods, JH	1
Butelman, ER; DeCosta, BR; Walker, EA; Woods, JH	1
France, CP; Gerak, LR	2
House, JD; Makhay, MM; Walker, EA; Young, AM	1
Aksu, F; Fujimoto, JM; Holmes, BB	1
Amundsen, L; Binstock, W; Cox, SM; Faure, EA; Glosten, B; Hibbard, J; Ismail, M; Moawad, AH; Senal, JA; Wittels, B	1
Walker, EA; Young, AM	1
Brandt, MR; France, CP	2
Ho, ST; Lee, SC; Tao, PL; Wang, JJ	1
Butelman, ER; Ko, MC; Mosberg, HI; Sobczyk-Kojiro, K; Van Bemmel, B; Woods, JH; Zernig, G	1
Bagley, JR; Brandt, MR; Brockunier, LL; France, CP; Gerak, LR; Landers, LK; Lelas, S	1
Morgan, D; Picker, MJ	1
Bartok, RE; Craft, RM; Heideman, LM	1
Clark, MJ; Emmerson, PJ; Medzihradsky, F; Remmers, AE	1
Dykstra, LA; Hawkins, ER; Picker, MJ; Tiano, MJ; Walker, EA	1
Sutherland, J; Walker, EA; Young, AM; Zhang, L	1
Bergman, J; Carey, GJ	1
Craft, RM; McNiel, DM	1
France, CP; McMahon, LR; Sell, SL	1
Holtzman, SG; White, DA	1
Boyce, D; Carr, DB; McNicol, ED; Schumann, R	1
Meerpohl, JJ; Timmer, A	1
Bing, G; Jang, CG; Kim, HC; Koo, KH; Nabeshima, T; Oh, CH; Oh, KW; Park, DH; Shin, EJ; Yamada, K	1
Fisher, MC; Lance, WR; Mays, T; McCollum, MP; Miller, MW; Nol, P; Wehtje, ME; Wolfe, LL	1
Candy, B; Jones, L; Larkin, PJ; Stone, P; Vickerstaff, V	1
Cowan, A; Dun, NJ; Inan, S	1

Reviews

7 review(s) available for naltrexone and nalbuphine

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recent progress in research on narcotic antagonists. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 1976, Volume: 20 Topics: Animals; Benzomorphans; Chemical Phenomena; Chemistry; Cyclazocine; Humans; In Vitro Techniques; Models, Biological; Morphinans; Morphine Derivatives; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pentazocine; Receptors, Opioid; Structure-Activity Relationship; Substance-Related Disorders; Thebaine	1976
Opiate receptor pharmacology: mixed agonist/antagonist narcotics. Contemporary anesthesia practice, 1983, Volume: 7 Topics: Analgesics, Opioid; Buprenorphine; Butorphanol; Endorphins; Humans; Nalbuphine; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid	1983
Mu-opioid antagonists for opioid-induced bowel dysfunction. The Cochrane database of systematic reviews, 2008, Apr-16, Issue:2 Topics: Constipation; Defecation; Gastrointestinal Agents; Humans; Intestinal Diseases; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Piperidines; Quaternary Ammonium Compounds; Receptors, Opioid, mu	2008
[News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction]. Zeitschrift fur Gastroenterologie, 2008, Volume: 46, Issue:9 Topics: Analgesics, Opioid; Clinical Trials as Topic; Constipation; Gastrointestinal Transit; Humans; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Piperidines; Quaternary Ammonium Compounds; Receptors, Opioid, mu	2008
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. The Cochrane database of systematic reviews, 2018, 06-05, Volume: 6 Topics: Constipation; Defecation; Female; Gastrointestinal Agents; Humans; Intestinal Diseases; Male; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Piperidines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Receptors, Opioid, mu	2018

Trials

1 trial(s) available for naltrexone and nalbuphine

Article	Year
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesthesia and analgesia, 1993, Volume: 77, Issue:5 Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Butorphanol; Cesarean Section; Female; Humans; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Pregnancy; Prospective Studies	1993

Other Studies

38 other study(ies) available for naltrexone and nalbuphine

Article	Year
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proceedings of the National Academy of Sciences of the United States of America, 1993, Jul-15, Volume: 90, Issue:14 Topics: Amino Acid Sequence; Animals; Base Sequence; Brain Chemistry; Cloning, Molecular; In Situ Hybridization; Mice; Molecular Sequence Data; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Somatostatin; RNA, Messenger; Sequence Homology, Amino Acid; Substrate Specificity; Tissue Distribution	1993
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors. Journal of medicinal chemistry, 2007, May-03, Volume: 50, Issue:9 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; CHO Cells; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Morphinans; Nalbuphine; Naloxone; Naltrexone; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship	2007
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Syntheses of novel high affinity ligands for opioid receptors. Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8 Topics: Analgesics, Opioid; Crystallography, X-Ray; Furans; Humans; Ligands; Naltrexone; Narcotic Antagonists; Protein Binding; Receptors, Opioid	2009
Assessment of CNS drug activity in rhesus monkeys by analysis of the EEG. Federation proceedings, 1976, Volume: 35, Issue:11 Topics: Amobarbital; Animals; Brain; Clorazepate Dipotassium; Codeine; Computers; Electroencephalography; Glutethimide; Haplorhini; Macaca mulatta; Morphine; Nalbuphine; Naloxone; Naltrexone	1976
Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:3 Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Injections, Spinal; Male; Mice; Nalbuphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, kappa	1992
Role of opioid antagonists in the rat liver ischemia model. Transplantation proceedings, 1991, Volume: 23, Issue:5 Topics: Animals; Calcium Channel Blockers; Hepatic Artery; Ischemia; Liver; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Portal Vein; Rats; Rats, Inbred Strains; Verapamil	1991
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:1 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Dose-Response Relationship, Drug; Levallorphan; Male; Methadone; Morphinans; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri	1990
The therapeutic efficacy of opiate antagonists in hemorrhagic shock. Resuscitation, 1989, Volume: 18, Issue:2-3 Topics: Animals; Dogs; Endorphins; Hemodynamics; Morphinans; Nalbuphine; Naloxone; Naltrexone; Shock, Hemorrhagic	1989
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu	1987
Internally standardized method for the determination of nalbuphine in human plasma by means of high performance liquid chromatography with electrochemical coulometric detection. Arzneimittel-Forschung, 1988, Volume: 38, Issue:12 Topics: Chromatography, High Pressure Liquid; Electrochemistry; Humans; Indicators and Reagents; Morphinans; Nalbuphine; Naltrexone; Quality Control; Reference Standards	1988
Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:1 Topics: Animals; Behavior, Animal; Fentanyl; Heart Rate; Macaca mulatta; Nalbuphine; Naltrexone; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiration; Self Administration	1995
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1 Topics: Alfentanil; Analgesics; Animals; Azocines; Benzimidazoles; Benzomorphans; Dose-Response Relationship, Drug; Female; Hot Temperature; Macaca mulatta; Male; Nalbuphine; Naltrexone; Nociceptors; Pyrrolidines; Receptors, Opioid; Tail	1993
Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3 Topics: Alfentanil; Analgesics; Animals; Behavior, Animal; Benzofurans; Female; Macaca mulatta; Male; Molecular Structure; Nalbuphine; Naltrexone; Narcotic Antagonists; Pyrrolidines	1994
In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:2 Topics: Analgesia; Animals; Benzomorphans; Buprenorphine; Discrimination, Psychological; Etorphine; Fentanyl; Male; Morphine; Nalbuphine; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu	1994
Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A. Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:2 Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Dynorphins; Injections, Intraventricular; Injections, Spinal; Levallorphan; Male; Mice; Mice, Inbred ICR; Morphine; Nalbuphine; Naltrexone; Nociceptors; Spinal Cord	1993
Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Ethylketocyclazocine; Male; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Self Administration	1993
Discriminative stimulus effects on enadoline in pigeons. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2 Topics: Animals; Benzofurans; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Dynorphins; Nalbuphine; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa	1996
Discriminative stimulus effects of nalbuphine in rhesus monkeys. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:2 Topics: Analgesics, Opioid; Animals; Cocaine; Dextroamphetamine; Discrimination Learning; Female; Macaca mulatta; Male; Nalbuphine; Naltrexone	1996
Nalbuphine coadministered with morphine prevents tolerance and dependence. Anesthesia and analgesia, 1997, Volume: 84, Issue:4 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Male; Morphine; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pyrrolidines; Rats; Rats, Sprague-Dawley	1997
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:2 Topics: Analgesics, Opioid; Animals; Benzofurans; Brain Chemistry; Butorphanol; Dose-Response Relationship, Drug; Hot Temperature; Macaca mulatta; Nalbuphine; Naltrexone; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa	1998
Pharmacological profile of a deuterium-substituted mirfentanil derivative, OHM10579, in rhesus monkeys. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:3 Topics: Analgesics; Animals; Behavior, Animal; Deuterium; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Fentanyl; Macaca mulatta; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pain Measurement; Respiratory Mechanics	1998
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor. Psychopharmacology, 1998, Volume: 140, Issue:1 Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu	1998
Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats. Drug and alcohol dependence, 1999, Jan-07, Volume: 53, Issue:2 Topics: Animals; Buprenorphine; Castration; Discrimination Learning; Female; Fentanyl; Gonadal Steroid Hormones; Injections; Male; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptors; Rats; Rats, Sprague-Dawley; Sex Characteristics	1999
Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy. Journal of neurochemistry, 1999, Volume: 73, Issue:1 Topics: Animals; Cell Line; Cell Membrane; Cholesterol Esters; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Glioma; Guanosine 5'-O-(3-Thiotriphosphate); Membrane Fluidity; Nalbuphine; Naltrexone; Narcotic Antagonists; Narcotics; Neuroblastoma; Protein Conformation; Rats; Receptors, Opioid, mu; Sodium Chloride; Sufentanil; Tumor Cells, Cultured; Viscosity	1999
Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons. Pharmacology, biochemistry, and behavior, 1999, Volume: 64, Issue:2 Topics: Analgesics, Opioid; Animals; Columbidae; Cues; Discrimination Learning; Discrimination, Psychological; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Reversal Learning	1999
Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology, 2000, Volume: 148, Issue:2 Topics: Analgesics, Opioid; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Fentanyl; Male; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu	2000
Chronic l-alpha-acetylmethadol (LAAM) in rhesus monkeys: tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:1 Topics: Analgesics, Opioid; Animals; Drug Tolerance; Dynorphins; Female; Ketamine; Macaca mulatta; Male; Methadyl Acetate; Nalbuphine; Naltrexone; Narcotics; Respiration	2000
Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1 Topics: Animals; Benzofurans; Discrimination Learning; Dose-Response Relationship, Drug; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri; Thiophenes	2001
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats. Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:1 Topics: Animals; Benzeneacetamides; Butorphanol; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Urination	2003
Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:3 Topics: Animals; Buprenorphine; Conditioning, Operant; Discrimination Learning; Female; Macaca mulatta; Male; Methadyl Acetate; Morphine; Nalbuphine; Naltrexone; Narcotics; Receptors, Opioid, mu	2003
Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:1 Topics: Analgesics, Opioid; Animals; Buprenorphine; Diprenorphine; Discrimination, Psychological; Dose-Response Relationship, Drug; Drinking; Drug Interactions; Generalization, Stimulus; Male; Meperidine; Mice; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Saimiri; Water Deprivation	2005
Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice. Drug and alcohol dependence, 2009, Sep-01, Volume: 104, Issue:1-2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Area Under Curve; Blotting, Western; Dopamine; Enkephalins; Gene Expression; Genes, fos; Mice; Mice, Knockout; Microdialysis; Motor Activity; Nalbuphine; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Protein Precursors; Receptors, Opioid, kappa; Reverse Transcriptase Polymerase Chain Reaction; Substance Withdrawal Syndrome	2009
Tissue Residue Levels after Immobilization of Rocky Mountain Elk ( Cervus elaphus nelsoni) using a Combination of Nalbuphine, Medetomidine, and Azaperone Antagonized with Naltrexone, Atipamezole, and Tolazoline. Journal of wildlife diseases, 2018, Volume: 54, Issue:2 Topics: Animals; Azaperone; Deer; Drug Combinations; Drug Residues; Female; Hypnotics and Sedatives; Imidazoles; Immobilization; Medetomidine; Nalbuphine; Naltrexone; Narcotic Antagonists; Narcotics; Tolazoline	2018
Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic. Molecules (Basel, Switzerland), 2021, Sep-11, Volume: 26, Issue:18 Topics: Animals; Antipruritics; Behavior, Animal; Chloroquine; Deoxycholic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Nalbuphine; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa; tat Gene Products, Human Immunodeficiency Virus	2021